Related Experiment Video
Updated: Feb 7, 2026

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices
Published on: August 1, 2025
Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study
Virginia Hernández-Gea1,2, Bogdan Procopet3, Álvaro Giráldez4
1Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic-Institut d'Investigacions Biomèdiques August Pi I i Sunyer, IMDIM, University of Barcelona, Barcelona, Spain.
Insights
Preemptive transjugular intrahepatic portosystemic shunt (p-TIPS) significantly lowers mortality in Child-Pugh C patients with acute variceal bleeding. It also reduces treatment failure and rebleeding in high-risk patients.
Area of Science:
- Hepatology
- Interventional Radiology
- Gastroenterology
Background:
- Patients with acute variceal bleeding (AVB) and advanced liver disease (Child-Pugh C or B with active bleeding) face high risks of treatment failure, rebleeding, and death.
- Preemptive transjugular intrahepatic portosystemic shunt (p-TIPS) shows potential to improve outcomes but is not widely adopted in clinical practice.
- This study aimed to validate the efficacy of p-TIPS in a large cohort of high-risk AVB patients.
Purpose of the Study:
- To evaluate the effectiveness of preemptive transjugular intrahepatic portosystemic shunt (p-TIPS) versus standard drug and endoscopic therapy (D+E) in high-risk patients with acute variceal bleeding (AVB).
- To assess the impact of p-TIPS on mortality, treatment failure, rebleeding, ascites, and hepatic encephalopathy in Child-Pugh C (CP-C) and Child-Pugh B with active bleeding (CP-B+AB) patients.
Main Methods:
- A multicenter, international, observational study involving 671 patients admitted with AVB and high risk for treatment failure.
- Patients were treated with either standard drug and endoscopic therapy (D+E) or preemptive transjugular intrahepatic portosystemic shunt (p-TIPS), based on center policy.
- Outcomes including mortality, treatment failure, rebleeding, ascites, and hepatic encephalopathy were compared between treatment groups.
Main Results:
- In Child-Pugh C patients, p-TIPS was associated with significantly lower 1-year mortality compared to D+E (22% vs. 47%, P=0.002).
- For Child-Pugh B with active bleeding patients, p-TIPS did not significantly improve the low mortality rate but reduced treatment failure and rebleeding.
- Across both high-risk groups, p-TIPS significantly decreased the incidence of treatment failure and rebleeding (1-year CIF 92% vs. 74% for D+E, P=0.017) and ascites development, without increasing hepatic encephalopathy.
Conclusions:
- Preemptive transjugular intrahepatic portosystemic shunt (p-TIPS) should be considered the primary treatment for Child-Pugh C patients experiencing acute variceal bleeding.
- Given its efficacy in preventing further bleeding and ascites, p-TIPS presents a valuable treatment strategy for Child-Pugh B patients with active bleeding.
Abstract:
Patients admitted with acute variceal bleeding (AVB) and Child-Pugh C score (CP-C) or Child-Pugh B plus active bleeding at endoscopy (CP-B+AB) are at high risk for treatment failure, rebleeding, and mortality. A preemptive transjugular intrahepatic portosystemic shunt (p-TIPS) has been shown to improve survival in these patients, but its use in clinical practice has been challenged and not routinely incorporated. The present study aimed to further validate the role of preemptive TIPS in a large number of high-risk patients. This multicenter, international, observational study included 671 patients from 34 centers admitted for AVB and high risk of treatment failure. Patients were managed according to current guidelines, and use of drugs and endoscopic therapy (D+E) or p-TIPS was based on individual center policy. p-TIPS in the setting of AVB is associated with a lower mortality in CP-C patients compared with D+E (1 year mortality 22% vs. 47% in D+E group; P = 0.002). Mortality rate in CP-B+AB patients was low, and p-TIPS did not improve it. In CP-C and CP-B+AB patients, p-TIPS reduced treatment failure and rebleeding (1-year cumulative incidence function probability of remaining free of the composite endpoint: 92% vs. 74% in the D+E group; P = 0.017) and development of de novo or worsening of previous ascites without increasing rates of hepatic encephalopathy. Conclusion: p-TIPS must be the treatment of choice in CP-C patients with AVB. Because of the strong benefit in preventing further bleeding and ascites, p-TIPS could be a good treatment strategy for CP-B+AB patients.
More Related Videos
Related Concept Videos
Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
Esophageal Varices-I: Introduction
Bleeding in Fresh Concrete
Bleeding can cause several issues in the concrete structure. Sometimes, the rising water gets trapped beneath large aggregate...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Naturalistic Observations
Predicting Reaction Outcomes

